Oxford Mail on MSN12h
University of Oxford part of £50m cancer research programme
Global biopharma company GSK has invested up to £50 million in a collaboration with Oxford University. The agreement establishes the GSK-Oxford Cancer Immuno-Prevention Programme, aimed at exploring ...
J.P. Morgan Sticks to Its Sell Rating for GlaxoSmithKline (GSK)
J.P. Morgan analyst James Gordon maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.40.
Hosted on MSN19h
New Cancer Vaccine Could Stop the Disease Before It Starts
Cancer has long been one of the most feared diseases in the world. Now, a groundbreaking development in vaccine technology ...
BBC17h
Radio Oxford - Listen Live - BBC Sounds
Wake up with Oxfordshire's latest news, great music and conversation with Sophie.